CELESTIAL THERAPEUTICS
Celestial Therapeutics specializes in the fields of biotechnology, therapeutics, and life science. Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious diseases, rare diseases, and cancers.
CELESTIAL THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2019-10-25
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.celestialtherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Google Apps For Business Typekit Squarespace Squarespace Hosted FullStory
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.celestialtherapeutics.com Semrush global rank: 5.8 M Semrush visits lastest month: 1.43 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013

More informations about "Celestial Therapeutics"
Celestial Therapeutics | Pioneering Science For Innovative Therapies
Leveraging the lessons learnt from nature and based on our inherent innate immunity, Celestial’s scientists are developing next generation antivirals, anti-inflammatories, mRNA vaccines and …See details»
Celestial Therapeutics - Crunchbase Company Profile & Funding
Organization. Celestial Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
CEPI partners with Celestial Therapeutics Inc to …
Jun 13, 2023 CEPI's efforts to improve rapid response mRNA technologies form part of the organization's $3.5 billion plan to compress vaccine ... consists of industry veterans and prominent academicians with a proven track record. To …See details»
Celestial Therapeutics - LinkedIn
Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious diseases, rare diseases and cancers.See details»
CELESTIAL THERAPEUTICS INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CELESTIAL THERAPEUTICS INC. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.See details»
Celestial Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Www.celestialtherapeutics.com. Startups | Holding Company | 2019 | California, United States | < 10 | www.celestialtherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. ... The …See details»
Celestial Therapeutics | Irvine, CA, USA Startup - Gust
Website celestialtherapeutics.com; Company Summary Celestial is developing a novel mRNA platform technology licensed in from Harvard. Celestial’s plan is to develop a new class of mRNA vaccines and therapeutics that are safer, more …See details»
Celestial Therapeutics - Company Profile - Tracxn
Oct 14, 2024 Celestial Therapeutics - Developer of mRNA-based vaccines and therapies for multiple diseases. Raised a total funding of $1.44M over 2 rounds. Founded by Leontis …See details»
Celestial Therapeutics - Overview, News & Competitors - ZoomInfo
View Celestial Therapeutics (www.celestetherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Celestial - Products, Competitors, Financials, Employees, …
Celestialtherapeutics.com. Overview & Products; Financials; People; Founded Year 2019. Stage Unattributed - II | Alive. Total Raised $3.46M. Last Raised $100K | 2 mos ago. Mosaic Score. …See details»
Celestial Therapeutics - VentureRadar
"Celestial Therapeutics Inc. is a new California biotech developing novel proteins for treatment of infectious diseases and inflammatory conditions.See details»
CELESTIAL THERAPEUTICS INC. - Golden
Celestial is a biopharmaceutical company focused on the development and commercialization of first in class of a new class of novel and groundbreaking lipid and mRNA therapeutics & …See details»
Celestial Therapeutics - Contacts, Employees, Board Members, …
Organization. Celestial Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of …See details»
CELESTIAL THERAPEUTICS INC | SBIR.gov
PROJECT SUMMARY Human respiratory syncytial virus (hRSV) infection has an estimated global incidence of 33 million cases in children younger than 5 years, with up to 234,000 dying …See details»
Celestial Therapeutics - Company Profile & Staff Directory
Celestial Therapeutics is developing novel therapies based on innovative and groundbreaking science to treat, prevent and cure infectious diseases, rare diseases and cancers.See details»
Award - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... [email protected]. …See details»
CEPI partners with Celestial Therapeutics Inc to develop self ...
Jun 13, 2023 CEPI’s efforts to improve rapid response mRNA technologies form part of the organization’s $3.5 billion plan to compress vaccine development timelines to 100 days, a goal …See details»
Celestial Therapeutics - VentureRadar
Similar Companies: Atriva Therapeutics Germany Privately Held ATRIVA aims to develop new antiviral therapies against different respiratory viral infections. Founded in 2015, ATRIVA …See details»
Celestial Therapeutics - Alien Technology Transfer
Website: https://www.celestialtherapeutics.com. Celestial Therapeutics’ researchers are actively working on groundbreaking advancements in the field of antivirals, anti-inflammatories, mRNA …See details»
Second-line cabozantinib after sorafenib treatment for ... - PubMed
Objective: In the phase 3 CELESTIAL trial, cabozantinib improved overall survival (OS) and progression-free survival (PFS) compared with placebo in patients with previously treated …See details»